Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Samas

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry|December 8, 2004
The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitorsWayne L Cody, Daniel D Holsworth, Noel A Powell, et al.
The Journal of Organic Chemistry|April 25, 2012
Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrileManjinder S Lall, Garrett Hoge, Tuan P Tran, et al.
Molecular Pharmaceutics|April 24, 2025
Deconstructing Annealing Phenomena in Modified Release Lipid MultiparticulatesKellyn M Patros Zagaja, Michael C Roy, Kavan Jakuba, et al.
Chemmedchem|December 17, 2011
Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidateLi Xing, Balekudru Devadas, Rajesh V Devraj, et al.
The Journal of Organic Chemistry|February 1, 2011
An asymmetric synthesis of (2S,5S)-5-substituted azepane-2-carboxylate derivativesDonn G Wishka, Marion Bédard, Katherine E Brighty, et al.
Journal of Medicinal Chemistry|November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced DesensitizationJennifer E Davoren, Deane Nason, Jotham Coe, et al.
Journal of Pharmaceutical Sciences|October 18, 2024
An integrated approach combining experimental, informatics and energetic methods for solid form derisking of PF-06282999Ghazala Sadiq, Shubham Sharma, Joanna S Stevens, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
ACS Chemical Neuroscience|October 8, 2016
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side EffectsTravis T Wager, Thomas Chappie, David Horton, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum productionLain-Yen Hu, Huangshu John Lei, Daniel Du, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|December 8, 2004
The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitorsWayne L Cody, Daniel D Holsworth, Noel A Powell, et al.
The Journal of Organic Chemistry|April 25, 2012
Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrileManjinder S Lall, Garrett Hoge, Tuan P Tran, et al.
Molecular Pharmaceutics|April 24, 2025
Deconstructing Annealing Phenomena in Modified Release Lipid MultiparticulatesKellyn M Patros Zagaja, Michael C Roy, Kavan Jakuba, et al.
Chemmedchem|December 17, 2011
Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidateLi Xing, Balekudru Devadas, Rajesh V Devraj, et al.
The Journal of Organic Chemistry|February 1, 2011
An asymmetric synthesis of (2S,5S)-5-substituted azepane-2-carboxylate derivativesDonn G Wishka, Marion Bédard, Katherine E Brighty, et al.
Journal of Medicinal Chemistry|November 16, 2018
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced DesensitizationJennifer E Davoren, Deane Nason, Jotham Coe, et al.
Journal of Pharmaceutical Sciences|October 18, 2024
An integrated approach combining experimental, informatics and energetic methods for solid form derisking of PF-06282999Ghazala Sadiq, Shubham Sharma, Joanna S Stevens, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
ACS Chemical Neuroscience|October 8, 2016
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side EffectsTravis T Wager, Thomas Chappie, David Horton, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum productionLain-Yen Hu, Huangshu John Lei, Daniel Du, et al.
Pageof 3